In other words, a non-painful stimulus – like when you rub your shin after walking into a table – can overtake slower pain ...
T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback